Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
A Study Testing How Well LTG-001 Works and Its Safety in Patients with Knee Osteoarthritis
DenmarkTesting the Safety of Combining Tocilizumab with Other Biologic Drugs in Patients with Rheumatoid Arthritis or Psoriatic Arthritis
SpainComparing certolizumab pegol and belimumab for patients with moderate or severe systemic lupus erythematosus
PolandStudy of TOL2 safety and immune response in patients with generalized myasthenia gravis
DenmarkStudy of B Cell Response to Tetanus Toxoid Vaccination in Patients with Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis
The NetherlandsEvaluation of BIO-101 versus placebo for treating severe sarcopenia in elderly patients with reduced mobility
BelgiumStudy of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment
AustriaStudy of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments
SwedenStudy of botulinum toxin injections to treat pain in patients with piriformis muscle syndrome
FranceStudy of tocilizumab compared to placebo in patients with chronic chondrocalcinosis who did not respond to standard treatments
FranceEvaluating Safety and Effectiveness of Combining Biologic Medications for Patients with Rheumatoid Arthritis and Psoriatic Arthritis
SpainStudy of ropivacaine, sodium chloride and gadoteric acid in nerve blocks for hip pain in healthy volunteers
DenmarkThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
